chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a contactable consumer (patient). This consumer reported similar events for 2 patients. This is 1st of 2 reports. A 73-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9264) via an unspecified route of administration on 30Jan2021 13:00 (at the age of 73-year-old), received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL9266) via an unspecified route of administration on 20Feb2021 12:45 (at the age of 73-year-old), both in arm left, at single dose, for COVID-19 immunisation. Medical history included Type 2 Diabetes. No Known allergies. Concomitant medications in two weeks included atorvastatin, metoprolol succinate, ramipril, and "H". The patient previously received first dose of BNT162B2 (lot number: EL9264) on 30Jan2021 01:00 PM (at the age of 73-year-old) in left arm for COVID-19 immunisation. Patient did not receive other vaccine in four weeks and did not have COVID prior vaccination. Patient tested positive for the COVID virus after receiving the 2nd dose on 03May2021 with positive result of COVID Antigen and PCR (Nasal Swab). AE resulted in Doctor or other healthcare professional office/clinic visit. Patient received treatment for AE. The outcome of the event was recovered in May2021.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021529304 Same reporter, event, vaccine/different patient
Pt had received Hep A on Nov 6, 2009 at the clinic. He was scheduled to receive his 4 year old shots on 01/28/10. He received a 2nd Hep A on that date. There were no adverse events at that time. Mom called today (3/9/10) wanting to know why he received shot earlier than he should have.
Told has arthritis in neck from C3 or C4 to C6; Cannot get comfortable at night because of her neck; Arthritis at C3-C4 down to C6; Pain in neck; This is a spontaneous report from a contactable consumer or other non HCP (Patient). A 75-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: ER2613), via an unspecified route of administration on 25Mar2021 (at the age of 74-years-old) as DOSE 2, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Prior Vaccinations any other vaccinations within four weeks prior to the first administration date of the suspect vaccine was reported as None. It was reported that patient was healthy at the time of vaccination. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EN6205), via an unspecified route of administration on 03Mar2021 (at the age of 74-years-old) as dose 1, single for COVID-19 immunisation. Patient wants to speak with a medical professional about side effects she had since received the Covid 19 Vaccine. she stated that she had her second shot at the end of Mar2021. Six weeks later, in the middle of May, she started to experience pain in her neck. The pain continued and she went to the doctor. She had x-rays done and was told that she had arthritis in her neck from C3 or C4 to C6. Patient Stated that she never had a problem with her neck and it seems like it may be related to the vaccine. States she wants to know from a professional if that is a possibility. She was very frustrated and she cannot get comfortable at night because of her neck. The doctor told her to use Advil, it did not help a whole lot, just some. When she told the doctor that she thought it might be related to the Covid Vaccine he told her at least she didn't get Covid 19. The patient underwent lab tests and procedures which included x-ray: arthritis in neck on 2021. Therapeutic measures was taken for the events treatment received with Advil. The outcome of Pain in neck was not recovered and outcome of arthritis in neck from C3 or C4 to C6, cannot get comfortable at night because of her neck, Arthritis at C3-C4 down to C6 was unknown.  Follow-up attempts are completed. No further information is expected.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for COVID-19 immunisation; bnt162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history included: "COVID-19" (unspecified if ongoing), notes: before the vaccines came out. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jan2023) She had COVID-19. Additional information: The patient called as she wanted to know how effective the vaccine was. She had her 5th vaccine in Apr2023 and was asking how long it will last. She had COVID-19 before the vaccines came out and got all the Pfizer COVID-19 vaccines and she still had COVID-19 every year. Her husband got all Moderna vaccines and he never got COVID-19. The patient stated that Moderna vaccines are better than Pfizer vaccines. The last time she had COVID-19 was in Jan2023.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5, bnt162b2 has been requested and will be submitted if and when received.
Chills; Headache; Nausea; I have Lymphedema that's acting up and it's never acted for like 20 years; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), on 26Jun2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Lymphedema" (ongoing). The patient took concomitant medications. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunisation; Covid-19 vaccine (First booster dose, Unknown manufacturer), for COVID-19 immunisation. The following information was reported: CHILLS (non-serious) with onset 2022, outcome "unknown"; HEADACHE (non-serious) with onset 2022, outcome "unknown"; LYMPHOEDEMA (non-serious) with onset 2022, outcome "unknown", described as "I have Lymphedema that's acting up and it's never acted for like 20 years"; NAUSEA (non-serious) with onset 2022, outcome "unknown".  Additional information: The patient reported of having the 2nd booster about, on the 26th, which was like 9 days ago and my body is feeling like, I have chills and headache and nausea and also, I have Lymphedema that's acting up and it's never acted for like 20 years. So are those possible things to that might happen when I have this vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Mouth soars. Blisters that are in the back of my mouth started to come up in a few hours after the shot. Large in size.
PATIENT RECEIVED BOOSTER TOO SOON- FISRST DOSE 04/05/2021-SECOND DOSE 04/11/2022-BOOSTER-05/02/2022. UPON REGISTERING CLIENT WAS NOT CONFIREMED ON PREVIOUS DOSED AND THAT WAS GIVEN ON LAST YEAR. PATIENT FIRST VISIT ON THE 04/11/2022 DID NOT SEE ANY CODES IN THE SYSTEM AND CLIENT COULD NOT REMEMBER IF HE RECIEVED VACCINCE
This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tenderness), PYREXIA (Fever), HEADACHE (Terrible headache), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Soreness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TENDERNESS (Tenderness), PYREXIA (Fever), HEADACHE (Terrible headache), FATIGUE (Fatigue), VACCINATION SITE PAIN (Soreness), MYALGIA (Body ache) and CHILLS (Chills). At the time of the report, TENDERNESS (Tenderness), PYREXIA (Fever), HEADACHE (Terrible headache), FATIGUE (Fatigue), VACCINATION SITE PAIN (Soreness) and CHILLS (Chills) outcome was unknown and MYALGIA (Body ache) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
101 Temperature; Headache; Chills; Fatigue; This is a spontaneous report from a contactable healthcare professional. A 50-year-old male patient received his first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on his right arm, via an unspecified route of administration on 13Jan2021 09:15 at a single dose for COVID-19 immunization. Medical history included covid-19.  Concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient experienced 101 Temperature, Headache, Chills, Fatigue; all on 13Jan2021. The patient did not receive any treatment for the events. The outcome of the events was recovering.  No follow-up attempts are possible, information about lot/batch cannot be obtained. No further information is expected.
77y/o male with h/o of HTN , HLD, Carotid artery stenosis, osteoarthritis, prostate cancer s/p, lung cancer s/p recent lobectomy on 9/27 who presents with 1 day hstory of fatigue, shortness of breath, chest tightness and general malaise. He was just discharged home yesterday 10/1 from a LLL lobectomy in stable condition. In the ED he was found to be in new onset afib with RVR, with CTPA negative for PE , but positive for postsurgical changes including small apical hydropneumothorax. Doctor saw the patient in the ED. He was given 3 dose of 5 mg of IV Metoprolol for  Atrial Fib with RVR with rates into the low 100s. He will be admitted with new onset afib with RVR and NSTEMI likely type 2 in the setting of recent Left Lower Lobectomy.  10/4/2021 Afib with RVR resolved on discharged.
Menstrual irregularities including severe cramping, heavy bleeding despite having an IUD that until I got the vaccine made my periods very very light.
Chest pain, like extremely bad heartburn, with mild nausea. Pain peaked and ebbed over 6 hours and was unaffected by Acetaminophen. When pain stopped, the chest muscle ached the next 5 days after and physical activity caused the ache to get more noticeable
Follow up: Patient received casirivimab instead of intended COVID vaccine.  48-hr follow up didn't identify AEs. Patient Patient received COVID vaccine on December 31.
chills; fever /running fever/fever like 100; This is a spontaneous report from a contactable consumer (patient) from medical information team. A 53-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number: ER2613, expiration date was not reported) via an unspecified route of administration, in left arm, on 22Mar2021 (at the age of 53-year-old), at dose 1, single for covid-19 immunization. Medical history included kidney transplant, diabetic and high blood pressure. Concomitant medications included tacrolimus as anti-rejection medicine; insulin aspart (NOVOLOG) taken for insulin, nifedipine taken for blood pressure (as blood pressure pill). The patient experienced chills and fever /running fever/fever like 100 from the last Wednesday on 24Mar2021. There were no investigation assessments. Therapeutic measures were taken included Tylenol. The outcome of the events was unknown.   No follow-up attempts are possible. No further information is expected.
Information has been received from a physician concerning a 73 year old white female with penicillin allergy and hospitalized for a minor unspecified GYN procedure and a history of splenectomy (due to lymphoma)and knee replacement who on 29-JUL-2005 (before discharge from hospital) was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine.  Concomitant therapy included estradiol (ESTRACE) and medroxyprogesterone acetate (PROVERA).  On 30-JUL-2005 the patient developed a fever of over 102 F for three days.  The patient was prescribed ibuprofen (MOTRIN), acetamiphen (TYLENOL) and levofloxacin (LEVAQUIN).  A cat scan was negative.  The patient recovered.  No product quality complaint involved.  Additional information is not expected.
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On an unknown date, the patient was vaccinated with improper stored GARDASIL 9 (lot# R009614, expiration date: 30-NOV-2020, strength, dose, frequency and route were unknown) for prophylaxis (Product storage error). The vaccines had temperature excursion of 32 F to 35 F (34.9) for 1 hour 10 minutes and 47 F to 77 F (51.6F) for 1 hour 5 minutes Previous temperature excursion was 32 degree F up to 35 degree F for 3 hours 12 minutes. The call was due to the digital data logger. No adverse event was reported. No product quality complaint involved.
ADVERSE EVENT NOS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported. On an unspecified date, the patient experienced adverse event nos. The action taken with covid-19 vaccine was not applicable. The outcome of adverse event nos was not reported. This report was non-serious.
Patient experienced pain at injection site and difuse redness over most of the upper bicep/deltoid portion of her arm. The site of reaction was warm to the touch, slightly swollen, and did not itch. Patient reports this rash started within 12 hours of getting the vaccine. She has gotten the FLUZONE HD vaccine in the past without issue, this was her first PNEUMOVAX 23 vaccine. The reaction was localized to the arm in which the vaccines were given, no systemic effects including difficulty of breathing or hives was experienced by the patient. She treated the pain  with ibuprofen and Tylenol, as well as icing the arm, which helped "a little". Advised patient to take benedryl to help with the redness and swelling of the arm.
Severe fatigue, severe muscle aches, red and swollen at the site of injection, PERIODS OF RAPID HEART RATE
Significant headache, fatigue, body aches, chills. Started about 20 hours after injection and by 72 hours was all gone.
chills / chills on and off; extreme weakness all over; muscle arm soreness; vomiting; mild muscle weakness; This spontaneous case was reported by a patient and describes the occurrence of CHILLS (chills / chills on and off), ASTHENIA (extreme weakness all over), MYALGIA (muscle arm soreness), VOMITING (vomiting) and MUSCULAR WEAKNESS (mild muscle weakness) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills / chills on and off), ASTHENIA (extreme weakness all over), MYALGIA (muscle arm soreness), VOMITING (vomiting) and MUSCULAR WEAKNESS (mild muscle weakness). At the time of the report, CHILLS (chills / chills on and off), ASTHENIA (extreme weakness all over), MYALGIA (muscle arm soreness), VOMITING (vomiting) and MUSCULAR WEAKNESS (mild muscle weakness) outcome was unknown.            Concomitant medication was not provided. Treatment information was not provided.   This case was linked to MOD-2021-194168 (Patient Link).
patient got INFLUENZA VACCINE every year but a few times patient was sick with the flue all winter; Initial information received regarding an unsolicited valid non-serious case received from a consumer (patient) via Social media (and transmitted to Sanofi on 01-Nov-2020.  This case involves an unknown age patient got INFLUENZA VACCINE every year but a few times patient was sick with the flue all winter (Influenza).  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On an unknown date every year, the patient received INFLUENZA VACCINE (produced by unknown manufacturer) (lot number Unknown) via unknown route in unknown administration site for prophylactic vaccination but a few times patient was sick with the flue all winter (Influenza).  Final diagnosis was Influenza.   No laboratory tests were reported.  It was not reported if the patient received a corrective treatment.  Event outcome was reported as Unknown for Influenza.  Lot number was not reported for this case.
Heart palpitations, instant racing heart when bending down. Chest pressure, chest pain, excessive heart burn that is intermittent after palpitation/heart flutter and episodes.
Stiffness and pain in thumb knuckle/ hurts to move on the hand on the side where I received a vaccine pain and wrist/mild tingling
eczema; Initial information was received on 24-Oct-2021 regarding an unsolicited valid non-serious case from a consumer/non-healthcare professional via social media.  This case involves an adult (unknown gender) patient who had eczema, after receiving INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE [FLUZONE].  It was unknown if the patient had any medical history, concomitant disease or risk factor.  The patient's past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On an unknown date (5 years ago), the patient received a dose of suspect INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE [FLUZONE] (lot number and expiry date not reported) via unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious eczema (unknown latency) following the administration of vaccination.  It was reported " When I stopped getting flu Vax my eczema stopped. 5 years ago"  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome of the events was unknown.  There will be no information available on the batch number for this case.
left shoulder joint/muscle aching and pain with abduction and internal and external rotation-- with no history of prior trauma or joint issues.  Symptoms are still present three weeks later and hinder normal activities of daily living
Fever and chills began around 3 am following vaccination at 6:45 PM.  Upon arising around 7 am,  fainted in bathroom and was dizzy when upright for about thirty minutes.   Bruised ribs secondary to falling.
This is a spontaneous report from a contactable Pediatrician reported for her son. A 19-year-old male patient received TRUMENBA at single dose via unspecified route at the left arm on 22Jun2018 14:45. On the same date the patient also received the second dose of MENACTRA via unspecified route at the right arm. The patient had no medical history. On the same date the patient progressively worsening stiffening of the shoulder joint and pain, frozen shoulder and had severe limitation of the active lifting; Limitation of external rotation. Treatment of shoulder pain was "MOTRIN or TYLENOL." The outcome of the events was not recovered. The pediatrician stated that he had no doubt that the events are related to the vaccine. They are a very acute injury.
Noticed left arm began itching last night.  This morning, my arm was hot, red, swollen with a red streak across my upper arm.Put cold compress on arm around 2:00 pm as my wife was concerned.  She called her nurse on call line and they told her to watch it and try to have it looked at in 24 hours if not better..
About 12 hours the first vaccine: body ache, chills, low grad fever (99.1), exhaustion. These symptoms went away in about 48 hours. A few days after the first does, swelling of both lymph nodes in left and right arm pits and inflammation in the palm of my hand under the middle finger. The lymph node swelling went away in about one week. The hand inflammation is still present.   About 12 hours after the second vaccine: body ache and extreme exhaustion and brain fog. These symptoms went away after 24 hours. A few days after the second does, swelling of both lymph nodes in left and right arm pits. The swelling symptoms went away after about one week.
Patient reported nausea and was treated with Zofran ODT 4mg x 2.  Resolved in 30 minutes.
fever; severe chills; diarrhea; vomiting; loss of taste and smell; extreme fatigue
PATIENT THOUGHT HER HAND WAS SWOLLEN. HER ARM AT INJECTION SITE WAS NOT RED OR SWOLLEN. I COULD NOT TELL IF HER HAND WAS SWOLLEN OR NOT, BUT SHE WAS CONCERNED IT WAS FROM VACCINE.
States feeling dizzy and woozy. BP 122/80, P 80, Temp 98.4.
Redness of the legs; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness of the legs) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event and Back surgery.   On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced ERYTHEMA (Redness of the legs). At the time of the report, ERYTHEMA (Redness of the legs) outcome was unknown.
I presented with severe onset of rheumatoid arthritis one month after getting vaccine.  Never had symptoms prior to vaccine.